What is Epionce?
Founded in 2002 and based in Boise, Idaho, Epionce (Episciences, Inc.) has developed a comprehensive, non-prescription dermatological product line integrating over two decades of research. The company's cosmeceutical offerings are designed to optimize skin health and appearance by targeting the skin's inherent protective and reparative systems. Utilizing a unique sub-layer delivery system and patent-pending botanical formulations, Epionce aims to provide powerful therapeutic benefits, strengthen skin function, and reverse inflammation. The effectiveness of its formulations for common skin diseases, conditions, and aging has been validated through multiple independent clinical studies, positioning Epionce as a scientifically-backed innovator in the skin wellness sector.
How much funding has Epionce raised?
Epionce has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Epionce?
The recent major strategic investment signals a pivotal growth phase for Epionce. This capital infusion is likely to fuel advancements in product development, expand market reach through its professional retail channels (dermatologists, plastic surgeons), and potentially enhance research and development efforts. The company's focus on scientifically proven, patent-pending formulations suggests a strategy centered on innovation and efficacy, aiming to further solidify its position as a leader in evidence-based skincare solutions.
See full Epionce company page
